EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Pituitary Immune Environment and Immunotherapy: From Hypophysitis to Pituitary Neuroendocrine Tumors

Toru Tateno iD, Mariam Shahidi iD, Jian-Qiang Lu iD, Constance Chik iD

Cells · 2025

DOI: 10.3390/cells14181450 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Toru Tateno und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Immunotherapy, Pituitary Neoplasms, Pituitary Gland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Translational Research Implementation Fund from the University of Alberta's Department of Medicine, The Translational Research Implementation Fund from the University of Alberta’s Department of Medicine, Translational Research Implementation Fund 2024.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immune landscape plays an important role in various pituitary diseases, ranging from hypophysitis to pituitary neuroendocrine tumors. Moreover, the use of immune checkpoint inhibitors (ICIs) has dramatically altered the landscape of cancer treatment by improving prognosis and overall survival in a multitude of advanced-staged malignancies, though their use in pituitary neuroendocrine tumors has remained limited. In this review, we will focus on selected topics to highlight the impact of the immune microenvironment on the function of the pituitary gland, namely, animal models of autoimmune hypophysitis, including ICI-induced hypophysitis as a common adverse event, and the importance of its early recognition in patients treated with ICIs. Using a case, we will provide an overview on the epidemiology, pathogenesis, clinical spectrum, diagnosis, predictors, and management of ICI-induced hypophysitis. We will also summarize the role of the immune microenvironment in pituitary neuroendocrine tumors with programmed cell death ligand 1 as a biomarker for treatment. Lastly, we will review the role of ICIs in the management of 40 patients with aggressive and metastatic pituitary neuroendocrine tumors. Current knowledge gaps in these topics will also be highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsImmunotherapyPituitary NeoplasmsPituitary GlandHypophysitisTumor MicroenvironmentHumansAnimalsImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

aggressive pituitary neuroendocrine tumorshypophysitisimmune checkpoint inhibitorsimmune microenvironmentimmunotherapyprogrammed cell death ligand 1

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada.
  • Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada.

ORCID-Profile: Toru Tateno, Mariam Shahidi, Jian-Qiang Lu, Constance Chik

Förderung

  • The Translational Research Implementation Fund from the University of Alberta's Department of Medicine
  • The Translational Research Implementation Fund from the University of Alberta’s Department of Medicine
  • Translational Research Implementation Fund 2024

Zitieren

APA

Tateno, T., Shahidi, M., Lu, J. Q., & Chik, C. (2025). The Pituitary Immune Environment and Immunotherapy: From Hypophysitis to Pituitary Neuroendocrine Tumors. Cells. https://doi.org/10.3390/cells14181450

Vancouver

Tateno T, Shahidi M, Lu JQ, Chik C. The Pituitary Immune Environment and Immunotherapy: From Hypophysitis to Pituitary Neuroendocrine Tumors. Cells. 2025. doi:10.3390/cells14181450

BibTeX
@article{Tateno2025,
  author = {Tateno, Toru and Shahidi, Mariam and Lu, Jian-Qiang and Chik, Constance},
  title = {The Pituitary Immune Environment and Immunotherapy: From Hypophysitis to Pituitary Neuroendocrine Tumors},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14181450}
}
Kostenlos starten →